^
Association details:
Biomarker:NF1 underexpression
Cancer:Neuroblastoma
Drug:Mektovi (binimetinib) (MEK inhibitor)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: D – Preclinical
New
Source:
Title:

Binimetinib inhibits MEK and is effective against neuroblastoma tumor cells with low NF1 expression

Excerpt:
...Cell lines sensitive to binimetinib treatment had the lowest NF1 protein levels, while resistant cell lines showed the highest levels of NF1 protein…Fig 5…
DOI:
10.1186/s12885-016-2199-z